1. Home
  2. CAPT vs ELUT Comparison

CAPT vs ELUT Comparison

Compare CAPT & ELUT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

CAPT

Captivision Inc.

HOLD

Current Price

$0.63

Market Cap

25.1M

Sector

Finance

ML Signal

HOLD

Logo Elutia Inc.

ELUT

Elutia Inc.

HOLD

Current Price

$0.69

Market Cap

25.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CAPT
ELUT
Founded
2005
2015
Country
South Korea
United States
Employees
N/A
N/A
Industry
Blank Checks
Medical Specialities
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
25.1M
25.2M
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
CAPT
ELUT
Price
$0.63
$0.69
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$7.00
AVG Volume (30 Days)
1.3M
250.4K
Earning Date
01-01-0001
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$17,389,944.00
$21,746,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
84.70
24.08
52 Week Low
$0.37
$0.58
52 Week High
$1.94
$4.84

Technical Indicators

Market Signals
Indicator
CAPT
ELUT
Relative Strength Index (RSI) 37.87 42.36
Support Level $0.71 $0.60
Resistance Level $0.88 $0.72
Average True Range (ATR) 0.08 0.07
MACD -0.01 0.01
Stochastic Oscillator 6.95 49.91

Price Performance

Historical Comparison
CAPT
ELUT

About CAPT Captivision Inc.

Captivision Inc Formerly Glaam Co Ltd is engaged in manufacturing, installing, and selling LED display G-Glass. G-Glass is an integrated ICT product that has the basic characteristics of transparent glass but can display media images at the same time. It implements media images through the glass surface while preserving the features of clear and transparent glass. G-Glass is the world's first IT building material that can be applied to various places where glass is used.

About ELUT Elutia Inc.

Elutia Inc Formerly Aziyo Biologics Inc is a commercial-stage regenerative medicine company focused on creating the next generation of differentiated products and improving outcomes in patients undergoing surgery, concentrating on patients receiving implantable medical devices. The company's segments include Device Protection, Women's Health and Cardiovascular. It generates maximum revenue from the Women's Health segment. The products of the company are targeted to address unmet clinical needs with the goal of promoting healthy tissue formation and avoiding complications associated with medical device implants, such as scar-tissue formation, capsular contraction, erosion, migration, non-union of implants and implant rejection.

Share on Social Networks: